Basic phospholipase A2 that inhibits ADP-, thrombin- and arachidonic acid-induced platelet aggregation (PubMed:30239061, PubMed:24384926). It also exhibits anticoagulant effects upon human plasma in vitro (PubMed:30239061). It induces a high hemolytic activity reaching its maximum after 24 hours (PubMed:24384926). It induces a marked elevation of plasmatic levels of interleukin-6 and -10, eosinophil peroxidase and complement lytic activities and it also provokes a drastic increase of lymphocytes, monocytes and neutrophils in peripheral blood accompanied by a rapid intense migration of neutrophils to the peritoneal cavity (PubMed:24384926). PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. a 1,2-diacyl-sn-glycero-3-phosphocholine + H2O = a 1-acyl-sn-glycero-3-phosphocholine + a fatty acid + H(+) Binds 1 Ca(2+) ion. Monomer. Expressed by the venom gland. Does not show significant fibrinogen-induced platelet aggregation. Belongs to the phospholipase A2 family. Group II subfamily. D49 sub-subfamily.